Find a Clinical Trial
Filter
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
VAPOR 2
Prostate cancer
All genders
50-89
Recruiting now
Department of Urology